Oculis Holding (OCS) Form 144 — 7,460 Shares Worth $148,230

Rhea-AI Filing Summary

Oculis Holding AG (OCS) filed a Form 144 reporting a proposed sale of 7,460 common shares, with an aggregate market value of $148,230.20, to be sold on 10/09/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The filer reports the shares were acquired and paid for on 10/09/2025 through an exercise of stock options and that payment was made in cash. The filing notes 43,662,402 shares outstanding and states there were no sales in the past three months by the same person. The notice includes the standard signature representation about no undisclosed material adverse information.

Positive

• Transaction is small relative to outstanding shares (7,460 vs 43,662,402), suggesting limited dilution or supply impact
• No reported sales in prior three months, indicating this is not part of a series of recent disposals

Negative

• No Rule 10b5-1 plan date provided, so the sale is not documented here as occurring under a pre-established trading plan

Insights

Equity Capital Markets Analyst

Insider exercised options and plans a modest sale of 7,460 shares valued at $148,230.

The transaction shows an option exercise and immediate proposed sale of the resulting common shares through Morgan Stanley Smith Barney on 10/09/2025. The reported $148,230.20 aggregate value is small relative to the reported 43,662,402 shares outstanding, indicating a limited direct impact on share supply.

The primary dependencies are the actual execution of the sale at the stated date and prevailing market price; the filing confirms no sales in the prior three months, which reduces the appearance of a larger, ongoing disposition. Monitor trade execution and any subsequent filings that would report completion or additional sales within the standard reporting window.

Corporate Governance Specialist

Filing includes the standard insider certification and trading-plan disclosure fields; no trading plan date was provided.

The signer attests they do not possess undisclosed material adverse information and the form offers a field for a Rule 10b5-1 plan date; that field is blank, indicating the sale is not explicitly tied to a disclosed trading plan in this notice.

Governance watchers should note the absence of a 10b5-1 adoption date and expect any related documentation or future disclosures if the sale proceeds under a pre-existing plan. This is a routine, traceable insider liquidity event with no additional governance flags in the filing itself.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7460	148230.20	43662402	10/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/09/2025	Exercise of Stock Options	Issuer			7460	10/09/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Oculis Holding AG (OCS) report on Form 144?

The filing reports a proposed sale of 7,460 common shares valued at $148,230.20 to be sold on 10/09/2025 on NASDAQ through Morgan Stanley Smith Barney LLC.

How were the shares acquired that are being sold?

The shares were acquired on 10/09/2025 by exercise of stock options and payment was made in cash on the same date.

Does the filing show other recent sales by the same person?

No. The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

How large is the position being sold relative to total shares outstanding?

The proposed sale of 7,460 shares is against 43,662,402 shares outstanding, a small fraction of the outstanding share count.

Is the sale disclosed as part of a Rule 10b5-1 trading plan?

No adoption date for a Rule 10b5-1 plan is provided in the notice, so the sale is not shown here as tied to a disclosed plan.